Developmental changes in brain serotonin synthesis capacity in autistic and nonautistic children

Annals of Neurology

Volumn 45, Issue 3, 1999, Pages 287-295

  Chugani, Diane C ^a,c   Muzik, Otto ^a   Behen, Michael ^a   Rothermel, Robert ^a   Janisse, James J ^b   Lee, Jennifer ^a   Chugani, Harry T ^a  

^a CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON 11; N METHYLTRYPTOPHAN; SEROTONIN;

ADOLESCENT; ADULT; AGE; ARTICLE; AUTISM; CHILD; CHILD DEVELOPMENT; CLINICAL ARTICLE; CONTROLLED STUDY; EPILEPSY; FEMALE; HUMAN; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SEROTONIN METABOLISM; SIBLING; SYNTHESIS;

ADOLESCENT; AGE DISTRIBUTION; AUTISTIC DISORDER; BRAIN; CHILD; CHILD BEHAVIOR; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; SEROTONIN; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0032987647     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8249(199903)45:3<287::AID-ANA3>3.0.CO;2-9     Document Type: Article

References (54)

1. Goldman-Rakic PS, Brown RM. Postnatal development of monoamine content and synthesis in the cerebral cortex of rhesus monkeys. Dev Brain Res 1982;4:339-349
2. Lidow MS, Goldman-Rakic PS, Rakic P. Synchronized overproduction of neurotransmitter receptors in diverse regions of the primate cerebral cortex. Proc Natl Acad Sci USA 1991;88: 10218-10221
3. Seifert WE Jr, Foxx JL, Butler IJ. Age effect on dopamine and serotonin metabolite levels in cerebrospinal fluid. Ann Neurol 1980;8:38-42
4. Hedner J, Lundell KH, Breese GR, et al. Developmental variations in CSF monoamine metabolites during childhood. Biol Neonate 1986;49:190-197
5. Hamon M, Bourgoin S. Possible role of serotonin and other monoamines as growth factors during brain development. Physiological and biochemical basis for perinatal medicine: Samuel Z. Levine conference, first international meeting, Paris, France, 1979:286-295
6. Lauder JM, Krebs H. Serotonin as a differentiation signal in early embryogenesis. Dev Neurosci 1978;1:15-30
7. Buznikov GA. The action of neurotransmitters and related substances on early embryogenesis. Pharmacol Ther 1984;25: 23-59
8. Lauder JM, Towle AC, Patrick K, et al. Decreased serotonin content of embryonic raphe neurons following maternal administration of p-chlorophenylalanine: a quantitative immunocytochemical study. Dev Brain Res 1985;20:107-114
9. Whitaker-Azmitia PM, Lauder JM, Shemmer A, Azmitia EC. Postnatal changes in serotonin1 receptors following prenatal alterations in serotonin levels: further evidence for functional fetal serotonin1 receptors. Dev Brain Res 1987;33:285-289
10. D'Amato RJ, Blue ME, Largent BL, et al. Ontogeny of the serotonergic projection to rat neocortex: transient expression of a dense innervation to primary sensory areas. Proc Natl Acad Sci USA 1987;84:4322-4326
11. Cases O, Seif I, Grimsby J, et al. Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA. Science 1995;268:1763-1766
12. Bennett-Clarke CA, Chiaia NL, Rhoades RW. Thalamocortical afferents in rat transiently express high-affinity serotonin uptake sites. Brain Res 1996;733:301-306
13. Lebrand C, Cases O, Adelbrecht C, et al. Transient uptake and storage of serotonin in developing thalamic neurons. Neuron 1996;17:823-835
14. Bennett-Clarke CA, Leslie MJ, Lane RD, Rhoades RW. Effect of serotonin depletion on vibrissae-related patterns in the rat's somatosensory cortex. J Neurosci 1994;14:7594-7607
15. Cases O, Vitalis T, Seif I, et al. Lack of barrels in the somatosensory cortex of monoamine oxidase A-deficient mice: role of a serotonin excess during the critical period. Neuron 1996;16: 297-307
16. Anderson GM. Studies on the neurochemistry of autism. In: Bauman ML, Kemper TL, eds. The neurobiology of autism. Baltimore: Johns Hopkins University Press, 1994:227-242
17. Schain RJ, Freedman DX. Studies on 5-hydroxyindole metabolism in autism and other mentally retarded children. J Pediatr 1961;59:315-320
18. McDougle CJ, Naylor ST, Cohen DJ, et al. Effects of tryptophan depletion in drug-free adults with autistic disorder. Arch Gen Psychiatry 1996;53:993-1000
19. Gordon CT, State RC, Nelson JE, et al. A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder. Arch Gen Psychiatry 1993;50:441-447
20. Cook EH, Rowlett R, Jaselskis C, et al. Fluoxetine treatment of children and adults with autistic disorder and mental retardation. J Am Acad Child Adolesc Psychiatry 1992;31:739-745
21. McDougle CJ, Naylor ST, Cohen DJ, et al. A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder. Arch Gen Psychiatry 1996;53:1001-1008
22. Cook EH, Courchesne R, Lord C, et al. Evidence of linkage between the serotonin transporter and autistic disorder. Mol Psychiatry 1997;2:247-250
23. Anderson GM, Horne WC, Chatterjee D, Cohen DJ. The hyperserotonemia of autism. Ann NY Acad Sci 1990;600:331-340
24. Cook EH. Autism: review of neurochemical investigation. Synapse 1990;6:292-308
25. Nishizawa S, Benkelfat C, Young SN, et al. Differences between males and females in rates of serotonin synthesis in human brain. Proc Natl Acad Sci USA 1997;94:5308-5313
26. 11C]alpha-methyl-tryptophan kinetics for the estimation of serotonin synthesis rate in vivo. J Cereb Blood Flow Metab 1997; 17:659-669
27. 11C]methyl-L-tryptophan. Synapse 1998;28:33-43
28. Chugani DC, Muzik O, Rothermel R, et al. Altered serotonin synthesis in the dentatothalamocortical pathway in autistic boys. Ann Neurol 1997;14:666-669
29. Lord C, Rutter M, LeCouteur A. Autism diagnostic interview-revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord 1994;24:659-685
30. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed. Washington, DC: American Psychiatric Association, 1994
31. 11C]methyl-L-tryptophan. J Label Comp Radiopharm 1995;37:619-621
32. 11C]methyl-L-tryptophan. Nucl Med Biol 1996;23:1005-1008
33. Muzik O, Chugani DC, Shen C, Chugani HT. Non-invasive imaging of serotonin synthesis rate using PET and alpha-methyl-tryptophan in autistic children. In: Carson RE, Daube-Witherspoon ME, Herscovitch P, eds. Quantitative functional brain imaging with positron emission tomography. San Diego: Academic Press, 1998:201-206
34. 18F]fluoro-L-DOPA kinetics. J Cereb Blood Flow Metab 1998;18:43-51
35. Wolf WA, Kuhn DM. The uptake and release of tryptophan and serotonin: an HPLC method to study the flux of endogenous 5-hydroxyindoles through synaptosomes. J Neurochem 1986;46:61-67
36. Muzik O, Behrendt DB, Mangner TJ, Chugani HT. Design of a pediatric protocol for quantitative brain FDG studies with PET not requiring invasive blood sampling. J Nucl Med 1994; 35:104 (Abstract)
37. Suhonen-Polvi H, Ruotsalainen U, Kinnala A, et al. FDG-PET in early infancy: simplified quantification methods to measure cerebral glucose utilization. J Nucl Med 1995;36:1249-1254
38. Chugani HT, Phelps ME, Mazziotta JC. Positron emission tomography study of human brain functional development. Ann Neurol 1987;22:487-497
39. Huttenlocher PR. Synaptic density in human frontal cortex -developmental changes and effects of aging. Brain Res 1979; 163:195-205
40. Hays WL. Statistics, 4th ed. Orlando, FL: Holt, Reinhart and Winston, 1988
41. Neter J, Wasserman W, Kutner M. Applied linear statistical models, 3rd ed. Boston: Irwin, 1990
42. 11C]-methyl-tryptophan positron emission tomography in normal and autistic adults. Soc Neurosci Abstr 1996;22:22 (Abstract)
43. Chadwick D, Jenner P, Reynolds EH. Serotonin metabolism in human epilepsy: the influence of anticonvulsant drugs. Ann Neurol 1977;1:218-224
44. Young SN, Gauthier S, Anderson GM, Purdy WC. Tryptophan, 5-hydroxyindoleacetic acid and indoleacetic acid in human cerebrospinal fluid: interrelationships and the influence of age, sex, epilepsy and anticonvulsant drugs. J Neurol Neurosurg Psychiatry 1980;43:438-445
45. Shaywitz BA, Cohen DJ, Bowers MB. Reduced cerebrospinal fluid 5-hydroxyindoleacetic acid and homovanillic acid in children with epilepsy. Neurology 1975;25:72-79
46. Tanner JM, Whitehouse RH, Marubini E, Resele LF. The adolescent growth spurt of boys and girls of the Harpenden growth. Ann Hum Biol 1976;3:109-126
47. Smith QR, Monna S, Aoyagi M, Rapoport SI. Kinetics of neutral amino acid transport across the blood-brain barrier. J Neurochem 1987;49:1651-1658
48. Bauman M, Kemper TL. Histoanatomic observations of the brain in early infantile autism. Neurology 1985;35:866-875
49. Bauman ML, Kemper TL. Neuroanatomic observations of the brain in autism. In: Bauman ML, Kemper TL, eds. The neurobiology of autism. Baltimore: Johns Hopkins University Press, 1994:119-141
50. Yan W, Wilson CC, Haring JH. Effects of neonatal serotonin depletion on the development of rat dentate granule cells. Dev Brain Res 1997;98:177-184
51. Miquel MC, Kia HK, Boni C, et al. Postnatal development and localization of 5-HT1A receptor mRNA in rat forebrain and cerebellum. Dev Brain Res 1994;80:149-157
52. Blue ME, Erzurumlu RS, Jhaveri S. A comparison of pattern formation by thalamocortical and serotonergic afferents in the rat barrel field cortex. Cereb Cortex 1991;1:380-389
53. Osterheld-Haas MC, Hornung JP. Laminar development of the mouse barrel cortex: effects of neurotoxins against monoamines. Exp Brain Res 1996;110:183-195
54. O'Neill M, Jones RS. Sensory-perceptual abnormalities in autism: a case for more research? J Autism Dev Disord 1997; 27:283-293